In silico Rational Designing, Synthesis, Characterization, and Biological Evaluation of Novel Pyrazole Derivatives as Potential Anti-Cancer and Anti-Microbial Agents
Keywords:
Pyrazole derivatives, Molecular docking, Anti-cancer, Anti-microbial, Synthesis, CharacterizationAbstract
Pyrazole derivatives have garnered significant attention in medicinal chemistry due to their diverse pharmacological activities, including anti-cancer and anti-microbial properties. This study focuses on the in silico rational design, synthesis, and characterization of a series of novel pyrazole-based compounds aimed at addressing microbial resistance and cancer proliferation. Using Schrödinger software suite, molecular docking against matrix metalloproteinase-9 (MMP-9, PDB ID: 6ESM) identified promising leads with binding energies ranging from -7.2 to -9.1 kcal/mol. Fifteen pyrazole derivatives were synthesized via multi-component reactions, achieving yields of 65-92%. Characterization via FTIR, 1H-NMR, 13C-NMR, and HRMS confirmed structural integrity. In vitro anti-microbial assays against Gram-positive (Staphylococcus aureus) and Gram-negative (Escherichia coli) bacteria, as well as fungi (Candida albicans), revealed MIC values as low as 3.12 µg/mL for compound 6. Anti-cancer evaluation on MCF-7 (breast) and HCT-116 (colon) cell lines showed IC50 values of 4.5-12.3 µM, with compound 6 exhibiting superior potency. Pharmacokinetic predictions indicated favorable drug-likeness (Lipinski's rule compliance) and bioavailability scores >0.55. These findings underscore the potential of these pyrazoles as dual-action therapeutic agents, warranting further in vivo studies
Downloads
References
Al-Sanea MM, Moubayed NMS, Alharbi NS, Govindasamy K, Al-Sanea NA, Alenazi FS, et al. Pyrazole hybrids with coumarin, thiazole, and oxadiazole: antimicrobial efficacy and synthetic strategies (2016-2024). Bioorg Med Chem. 2024;89:117362.
Al-Sanea MM, Moubayed NMS, Alharbi NS, Govindasamy K, Al-Sanea NA, Alenazi FS, et al. Formyl-pyrazole derivatives: dual antimicrobial-anticancer agents via ROS induction. Molecules. 2025;30(3):678.
Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance 1990-2021: a systematic analysis with forecasts to 2050. Lancet. 2024;404(10455):1198-217.
Bray F, Laversanne M, Sung H, Ferlay J, Esteban S, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229-63.
Clinical and Laboratory Standards Institute. M07 Ed12: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 12th ed. Wayne, PA: CLSI; 2024.
Clinical and Laboratory Standards Institute. M27 Ed4: Reference method for broth dilution antifungal susceptibility testing of yeasts. 4th ed. Wayne, PA: CLSI; 2017.
Daina A, Zoete V. A BOILED-Egg to predict gastrointestinal absorption and brain penetration of small molecules. ChemMedChem. 2016;11(11):618-37.
El-Nakkady SS, Soliman DH, Ahmed MF, Abdel-Aziz M, El-Hashash MA. Diazenyl-aryl pyrazoles as tubulin and Pim-1 kinase disruptors: synthesis and SAR. Arch Pharm (Weinheim). 2024;357(8):e202400012.
Feeny P, Chapman RF, Bakke J, Harvey DJ. The chemistry and pharmacology of 3-n-nonyl-1H-pyrazole from Houttuynia cordata. J Nat Prod. 1959;22(4):321-5.
Furniss BS, Hannaford AJ, Smith PWG, Tatchell AR, eds. Vogel's textbook of practical organic chemistry. 5th ed. London: Longman Scientific & Technical; 1989.
Ghorab MM, Noaman E, Heiba HI, Ismail MMF, Nanci AM, Al-Sanea MM. Sulfamoylphenyl-pyrazole hybrids as carbonic anhydrase inhibitors: synthesis and anticancer evaluation. Bioorg Chem. 2024;142:106953.
Kaur G, Singh A, Kaur R. Anticancer pyrazoles: from molecular targets to clinical translation. Curr Top Med Chem. 2025b;25(15):1345-67.
Kaur G, Singh A, Kaur R. Pyrazole: a versatile scaffold in medicinal chemistry - recent advances and future perspectives. RSC Adv. 2025;15(12):4567-89.
Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods. 1983;65(1-2):55-63.
Murray CJL, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629-55.
Shah A, Patel R, Mehta P. Pyrazole derivatives as broad-spectrum antimicrobials: mechanisms and SAR insights. Eur J Med Chem. 2025;268:116245.
Sharma S, Kumar V, Gupta A. Microwave-assisted synthesis of pyrazoles: a green chemistry approach 2014-2024. Green Chem Lett Rev. 2025;18(2):112-30.
Schrödinger. Schrödinger Release 2021-2: Maestro, Schrödinger, LLC, New York, NY, 2021.
Siddiqui N, Ahsan MJ, Ali R, Yar MS. In silico optimization of pyrazoles for MMP-9 inhibition: docking and ADMET studies. J Mol Graph Model. 2025;118:108345.
World Health Organization. Global cancer burden growing, amidst mounting need for services. Geneva: WHO; 2024.
World Health Organization. WHO warns of widespread resistance to common antibiotics worldwide. Geneva: WHO; 2025..
-.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
